Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Taieb · SciRah

Researcher profile · Semantic Scholar

J. Taieb

Share profile

J. Taieb — researcher profile on SciRah

h-index: 73
Works: 557
Citations: 24K

Most-cited papers

Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
G. Prager, J. Taieb, M. Fakih, F. Ciardiello +16 more
2023New England Journal of Medicine296 citations Open access
Semantic Scholar
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
J. Taieb, M. Svrcek, R. Cohen, D. Basile +2 more
2022European Journal of Cancer293 citations Open access
Semantic Scholar
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
M. Thibaudin, J. Fumet, B. Chibaudel, J. Bennouna +21 more
2023Nature Medicine106 citations Open access
Semantic Scholar
Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
P. Kasi, G. Fehringer, H. Taniguchi, N. Starling +18 more
2022JCO Precision Oncology92 citations Open access
Semantic Scholar
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review
D. Eshmuminov, Botirjon Aminjonov, R. Palm, G. Malleo +32 more
2023Annals of Surgical Oncology76 citations Open access
Semantic Scholar
A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification.
J. Delattre, Ayse Selcen Oguz Erdogan, R. Cohen, Q. Shi +7 more
2021Cancer Treatment Reviews76 citations Open access
Semantic Scholar
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer
E. Van Cutsem, J. Taieb, R. Yaeger, T. Yoshino +15 more
2023Journal of Clinical Oncology75 citations Open access
Semantic Scholar
Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
L. Marisa, Y. Blum, J. Taieb, M. Ayadi +16 more
2021Clinical Cancer Research58 citations Open access
Semantic Scholar
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study
S. Stintzing, K. Heinrich, D. Tougeron, D. Modest +16 more
2023Journal of Clinical Oncology52 citations Open access
Semantic Scholar
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials
D. Pietrasz, Shu-Fang Wang-Renault, J. Taieb, L. Dahan +12 more
2021British Journal of Cancer48 citations Open access
Semantic Scholar
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials
J. Taieb, F. Sinicrope, L. Pederson, S. Lonardi +12 more
2023Annals of Oncology44 citations Open access
Semantic Scholar
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
M. Etienne-Grimaldi, N. Pallet, V. Boige, J. Ciccolini +7 more
2022European Journal of Cancer42 citations Open access
Semantic Scholar
Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
D. Basile, C. Broudin, J. Emile, A. Falcoz +12 more
2022Annals of Oncology42 citations Open access
Semantic Scholar
Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study.
J. Tabernero, G. Prager, M. Fakih, F. Ciardiello +16 more
2023Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
M. Shah, T. Yoshino, N. Tebbutt, A. Grothey +16 more
2022Clinical colorectal cancer35 citations
Semantic Scholar
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors
C. Gallois, Matteo Landi, J. Taieb, M. Sroussi +18 more
2023Clinical Cancer Research29 citations Open access
Semantic Scholar
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials
C. Gallois, Q. Shi, J. Meyers, T. Iveson +20 more
2022Journal of Clinical Oncology26 citations Open access
Semantic Scholar
O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer
E. Van Cutsem, J. Taieb, R. Yaeger, T. Yoshino +15 more
2021Annals of Oncology25 citations Open access
Semantic Scholar
European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal cancer.
E. Martinelli, D. Arnold, A. Cervantes, S. Stintzing +5 more
2023Cancer Treatment Reviews23 citations Open access
Semantic Scholar
Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trials.
N. Christou, E. Bergen, C. Canton, K. Le Malicot +10 more
2022European Journal of Cancer21 citations Open access
Semantic Scholar
Re-Evaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
Jun Yin, M. Salem, J. Dixon, Zhao-Hui Jin +17 more
2021Journal of the National Cancer Institute20 citations Open access
Semantic Scholar
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
N. Williet, A. Petrillo, Gaël S. Roth, M. Ghidini +8 more
2021Cancers19 citations Open access
Semantic Scholar
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
J. Bachet, P. Laurent-Puig, A. Meurisse, O. Bouché +17 more
2023European Journal of Cancer18 citations Open access
Semantic Scholar
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
Quang-Loc Bui, L. Mas, A. Hollebecque, D. Tougeron +8 more
2022Cancers18 citations Open access
Semantic Scholar
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.
C. Rasola, P. Laurent-Puig, T. André, A. Falcoz +12 more
2023European Journal of Cancer16 citations Open access
Semantic Scholar
Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype
A. Ghazi, D. le Corre, C. Pilati, J. Taieb +10 more
2021Oncoimmunology16 citations Open access
Semantic Scholar
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
J. Taieb, T. Seufferlein, M. Reni, D. Palmer +7 more
2023BMC Cancer15 citations Open access
Semantic Scholar
Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 Patients
T. Helmberger, P. Lucatelli, P. Pereira, A. Gjoreski +10 more
2022Journal of Clinical Medicine15 citations Open access
Semantic Scholar
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
S. Zaibet, V. Hautefeuille, É. Auclin, A. Lièvre +11 more
2022British Journal of Cancer15 citations Open access
Semantic Scholar
Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study.
J. Taieb, S. Lonardi, J. Desai, G. Folprecht +5 more
2022Clinical colorectal cancer14 citations Open access
Semantic Scholar
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial.
C. Gallois, J. Emile, Stefano Kim, C. Montérymard +19 more
2021Digestive and Liver Disease14 citations Open access
Semantic Scholar
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors
É. Auclin, P. Vuagnat, C. Smolenschi, J. Taieb +16 more
2021Cancers14 citations Open access
Semantic Scholar
FOxTROT: Are We Ready to Dance?
J. Taieb, M. Karoui
2023Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis
T. Yoshino, J. Taieb, Y. Kuboki, P. Pfeiffer +2 more
2023Therapeutic Advances in Medical Oncology12 citations Open access
Semantic Scholar
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy
J. Taieb, T. Price, L. Vidot, Bénédicte Chevallier +2 more
2023BMC Cancer12 citations Open access
Semantic Scholar
Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series.
E. Hafliger, A. Boccaccino, A. Lapeyre-Prost, A. Perret +16 more
2022European Journal of Cancer12 citations Open access
Semantic Scholar
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study
E. van Veldhuisen, S. Klompmaker, Q. Janssen, M. Hilal +49 more
2022Annals of Surgical Oncology12 citations Open access
Semantic Scholar
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study
Cécile Torregrosa, S. Pernot, P. Vaflard, A. Perret +35 more
2022International Journal of Cancer11 citations
Semantic Scholar
Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49.
S. Pernot, O. Pellerin, L. Mineur, C. Montérymard +14 more
2022Digestive and Liver Disease11 citations Open access
Semantic Scholar
Postoperative hepatic arterial chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: A multicenter randomized phase II trial (PRODIGE 43 - PACHA-01).
M. Gelli, J. Ewald, M. Tanguy, G. Passot +16 more
2023Journal of Clinical Oncology10 citations
Semantic Scholar
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives
Cecilia Merk, A. Martling, J. Lindberg, L. Benhaim +2 more
2022Acta oncologica10 citations Open access
Semantic Scholar
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database.
G. Kafatos, V. Banks, P. Burdon, David Neasham +6 more
2021Future Oncology10 citations Open access
Semantic Scholar
FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty
J. R. Platt, O. Todd, P. Hall, Z. Craig +13 more
2022ESMO Open9 citations Open access
Semantic Scholar
LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial
J. Taieb, O. Bouché, T. André, E. Barbier +14 more
2022Annals of Oncology9 citations Open access
Semantic Scholar
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
Stefano Kim, V. Vendrely, A. Saint, T. André +19 more
2023Experimental Hematology & Oncology8 citations Open access
Semantic Scholar
BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma.
Raëf Abdallah, Shu-Lin Zhao, S. Garinet, K. Hormigos +10 more
2022Clinics And Research in Hepatology and Gastroenterology8 citations Open access
Semantic Scholar
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
V. Randrian, S. Pernot, K. Le Malicot, V. Catena +23 more
2022Digestive and Liver Disease8 citations Open access
Semantic Scholar
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
A. Lapeyre-Prost, G. Perkins, M. Vallee, A. Pozet +14 more
2021Clinics And Research in Hepatology and Gastroenterology8 citations Open access
Semantic Scholar
Screening for dihydropyrimidine dehydrogenase deficiency by measuring uracilemia in chronic kidney disease patients is associated with a high rate of false positives.
C. Narjoz, Z. Nadour, A. Zaanan, J. Taieb +2 more
2023Clinica chimica acta; international journal of clinical chemistry7 citations Open access
Semantic Scholar
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study
M. Auvray-Kuentz, V. Hautefeuille, L. de Mestier, C. Coutzac +15 more
2022International Journal of Cancer7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Tougeron×11
Invite
D. Tougeron — researcher profile on SciRah
P. Laurent-Puig×11
Invite
P. Laurent-Puig — researcher profile on SciRah
E. Van Cutsem×8
Invite
E. Van Cutsem — researcher profile on SciRah
T. Yoshino×8
Invite
T. Yoshino — researcher profile on SciRah

×7

Invite

J. Tabernero — researcher profile on SciRah

Invite

T. André — researcher profile on SciRah

Invite

C. Lepage — researcher profile on SciRah

Invite

S. Lonardi — researcher profile on SciRah

Invite

C. Gallois — researcher profile on SciRah

Invite

R. Cohen — researcher profile on SciRah

K. Le Malicot×6

Invite

K. Le Malicot — researcher profile on SciRah

Invite

J. Bachet — researcher profile on SciRah